Black checkmark with a sparkle and a curved line underneath on a white background.
Company

CIRTRAN CORP

Ticker
CIRX
Sector
Industry
Report date
November 14, 2026
Valye AI Score

100

Very high visibility
Recent developments
Recent developments summary

Recent news coverage relevant to CirTran is limited and mostly pertains to broader market and industry topics rather than company-specific developments.

Recent developments:
  • Alphabet's cloud revenue grew 103% last quarter, with the Gemini app reaching 1 billion monthly users, highlighting growth in cloud services [N1].
  • New inflation data presents challenges for the broader economy and AI-driven market trends [N2].
  • The FTC filed a lawsuit to block Covetrus' $3.5 billion acquisition of MWI Veterinary Supply, indicating regulatory scrutiny in related sectors [N3].
  • An analyst commented that SpaceX investors may undervalue AI's contribution to the company [N4].
  • Fabrinet's Q4 2026 earnings call transcript was published, providing insights into the contract manufacturing sector [N5].
  • UPS announced plans to invest over $2 billion in international, healthcare, and supply chain businesses [N6].
  • Corn prices held onto double-digit gains at midday, reflecting commodity market dynamics [N7].
  • A rout in chipmakers weighed on broader stock market indices, indicating sector volatility [N8].
Overview

CirTran Corporation operates in manufacturing, marketing, and distribution of a wide variety of consumer products, including tobacco products, medical devices, and beverages. The company conducts business through three subsidiaries and has established a presence in over 50 international markets. Its key business includes exclusive manufacturing and distribution of HUSTLER®-branded products such as condoms, electronic cigarettes, cigars, hookahs, energy drinks, and water beverages under an agreement with GloBrands, LLC. CirTran manages regulatory approvals and licenses necessary for its product lines, including FDA 510(k) clearance for condoms and tobacco import licenses. The company also pursues contract manufacturing and marketing relationships in domestic consumer product markets, providing full product lifecycle services from design to distribution. Offshore manufacturing in Asia and other regions is leveraged to control costs and increase capacity. CirTran faces competition from larger firms and internal manufacturing by customers. The company reported net sales of approximately $3.0 million and a net loss of $285,162 for the nine months ended September 30, 2026, with a low liquidity position as of that date.

Executive summary

CirTran Corporation is a diversified contract manufacturer and distributor of consumer products including tobacco, medical devices, and beverages, operating globally through subsidiaries. It holds exclusive manufacturing and distribution rights for HUSTLER®-branded products under license agreements. The company reported net sales of approximately $3.0 million and a net loss of $285,162 for the nine months ended September 30, 2026. As of that date, CirTran had current assets of $2.4 million and current liabilities of $25.3 million, resulting in a low liquidity position with a current ratio of 0.09 and cash ratio of 0.01. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.

Scenarios for CIRX

Bull case model:

CirTran's exclusive manufacturing and distribution rights for a recognized brand like HUSTLER® provide a platform for product commercialization across multiple consumer categories. Its diversified contract manufacturing capabilities and international supplier relationships offer potential operational scalability and cost efficiencies. The company's ability to provide full product lifecycle services from concept to consumer could attract OEMs seeking outsourcing solutions. Offshore manufacturing partnerships may enable competitive pricing and responsiveness to market demands. The company's ongoing efforts to expand product lines and distribution channels could enhance market presence over time.

Bear case model:

CirTran operates in highly competitive markets with limited market position and operating history, which may hinder its ability to secure exclusive marketing relationships and scale operations. The company's financials show a net loss and a low liquidity position with current liabilities significantly exceeding current assets, indicating potential financial stress. Dependence on licensing agreements subjects the company to risks of termination or non-renewal by licensors. Regulatory compliance costs and complexities may increase operational risks. Competition from larger firms and customers' internal manufacturing capabilities could limit growth opportunities and pricing power.

Moat:

CirTran's moat is primarily based on its exclusive licensing and manufacturing agreements, particularly with the Flynt/HUSTLER® organization and GloBrands, LLC, granting it rights to manufacture and distribute HUSTLER®-branded products globally. Its diversified expertise in contract manufacturing and established international manufacturing and distribution relationships provide operational flexibility and cost advantages. However, the company faces competition from larger firms with greater resources and from customers opting for internal manufacturing, which limits its competitive barriers. Regulatory compliance and licensing requirements also create operational complexity but are standard in the industry.

Risks overview
Risks summary
CirTran's most significant risk is its financial liquidity position, with current liabilities far exceeding current assets, which may impact its ability to sustain operations and meet obligations.
Risks details:

• Financial Liquidity Risk: As of September 30, 2026, CirTran had a current ratio of 0.09 and a cash ratio of 0.01, indicating limited short-term liquidity to cover current liabilities, which may constrain operational flexibility.
• Dependence on Licensing Agreements: The company's exclusive manufacturing and distribution rights depend on agreements with GloBrands and the Flynt/HUSTLER® organization, which can be terminated or not renewed, posing risks to product lines and revenue.
• Competitive Pressure: CirTran faces competition from larger companies with greater resources and from customers who may choose to manufacture internally, which could impact market share and profitability.
• Regulatory Compliance: The company must comply with various federal, state, and local regulations including FDA approvals and tobacco licensing, which involve costs and operational risks if not properly managed.

FINAL FORECAST FOR CIRX

Final take one line
CirTran Corporation operates a diversified contract manufacturing and distribution business with exclusive licensed products but faces liquidity challenges and competitive pressures.
Final take 12 to 24 month view

Business trends: Expansion of licensed consumer product manufacturing and contract manufacturing services with international supplier relationships.
Execution milestones: Maintaining regulatory approvals, managing licensing agreements, and scaling manufacturing and distribution capabilities.
Key risks: Financial liquidity constraints, dependence on licensing agreements, competitive market pressures, and regulatory compliance complexities.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

100
LLM visibility overview
LLM Visibility known facts
  • CirTran Corporation operates through three subsidiaries: LBC Products, Inc., CirTran Products Corp., and CirTran - Asia, Inc.
  • The company focuses on manufacturing, marketing, distribution, and technology services for consumer products including tobacco products, medical devices, beverages, and related merchandise.
  • CirTran has an exclusive manufacturing and distribution agreement with GloBrands, LLC to produce and sell HUSTLER®-branded products such as condoms, electronic cigarettes, cigars, hookahs, energy drinks, and water beverages.
  • The HUSTLER® brand is licensed from the Flynt/HUSTLER® organization, which operates clubs, retail stores, casinos, and media outlets globally.
  • CirTran manages regulatory approvals including FDA 510(k) clearance for condom manufacturing and tobacco import licenses as part of its operations.
  • The company pursues contract manufacturing and marketing relationships primarily in domestic consumer product markets, including home and garden, kitchen, health and beauty, toys, and licensed merchandise.
  • CirTran provides full product lifecycle services from design and prototyping to manufacturing, packaging, marketing, inventory control, distribution, and customer service.
  • The company leverages offshore manufacturing in Asia and other regions to control costs and increase capacity.
  • CirTran's business model includes contract manufacturing with turn-key services including design, engineering, procurement, testing, and distribution.
  • The company had 4 full-time employees and 23 part-time contract workers as of December 31, 2025, relying on contractors to minimize fixed overhead.
  • CirTran's financial snapshot as of September 30, 2026, shows current assets of approximately $2.4 million and current liabilities of about $25.3 million, resulting in a low current ratio of 0.09 and cash ratio of 0.01.
  • The company reported a net loss of $285,162 for the nine months ended September 30, 2026, with basic and diluted EPS of -$0.06.
  • Net sales for the nine months ended September 30, 2026, were approximately $3.0 million with a gross profit of about $1.3 million.
  • Operating expenses for the nine months ended September 30, 2026, totaled approximately $1.16 million, including employee costs and selling, general and administrative expenses.
  • CirTran's stockholders' deficit was approximately $23.3 million as of September 30, 2026.
  • The company faces competition from larger firms with greater resources and from customers who may choose internal manufacturing over outsourcing.
  • Regulatory compliance is a key aspect of CirTran's operations, including environmental, safety, labor, and product-specific regulations.
  • Recent news coverage includes broad market and industry topics but no direct recent news specifically about CirTran's business or operations.
Sources
Sources - Context summary

Generated 2026-11-14

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-04-15 | 10-K
  • S2 | 2026-11-13 | 10-Q
Sources - News headlines
  • N1 | 2026-11-14 | www.nasdaq.com | Sundar Pichai Reported Alphabet's Cloud Revenue Grew 103% Last Quarter While the Gemini App Reached 1 Billion Monthly Users. Is Google Cloud Becoming a Bigger Growth Driver Than Search? | https://www.nasdaq.com/articles/sundar-pichai-reported-alphabets-cloud-revenue-grew-103-last-quarter-while-gemini-app
  • N2 | 2026-11-14 | www.nasdaq.com | New Inflation Data Offers Terrible News for President Donald Trump's Economy and the AI-Driven Bull Market | https://www.nasdaq.com/articles/new-inflation-data-offers-terrible-news-president-donald-trumps-economy-and-ai-driven-bull
  • N3 | 2026-11-14 | www.nasdaq.com | FTC Sues To Block Covetrus' $3.5 Bln Acquisition Of MWI Veterinary Supply | https://www.nasdaq.com/articles/ftc-sues-block-covetrus-35-bln-acquisition-mwi-veterinary-supply
  • N4 | 2026-08-24 | www.nasdaq.com | Analyst to SpaceX Investors: You're Valuing SpaceX Like AI Is Almost Worthless | https://www.nasdaq.com/articles/analyst-spacex-investors-youre-valuing-spacex-ai-almost-worthless
  • N5 | 2026-08-24 | www.nasdaq.com | Fabrinet (FN) Q4 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/fabrinet-fn-q4-2026-earnings-call-transcript
  • N6 | 2026-08-24 | www.nasdaq.com | UPS To Invest More Than $2 Bln In International, Healthcare And Supply Chain Businesses | https://www.nasdaq.com/articles/ups-invest-more-2-bln-international-healthcare-and-supply-chain-businesses
  • N7 | 2026-08-24 | www.nasdaq.com | Corn Holding onto Double Digit Gains at Midday | https://www.nasdaq.com/articles/corn-holding-double-digit-gains-midday
  • N8 | 2026-08-24 | www.nasdaq.com | Rout in Chipmakers Weighs on Broader Market | https://www.nasdaq.com/articles/rout-chipmakers-weighs-broader-market
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine